Trousseau's syndrome

Jump to: navigation, search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for Trousseau's syndrome


Most recent articles on Trousseau's syndrome

Most cited articles on Trousseau's syndrome

Review articles on Trousseau's syndrome

Articles on Trousseau's syndrome in N Eng J Med, Lancet, BMJ


Powerpoint slides on Trousseau's syndrome

Images of Trousseau's syndrome

Photos of Trousseau's syndrome

Podcasts & MP3s on Trousseau's syndrome

Videos on Trousseau's syndrome

Evidence Based Medicine

Cochrane Collaboration on Trousseau's syndrome

Bandolier on Trousseau's syndrome

TRIP on Trousseau's syndrome

Clinical Trials

Ongoing Trials on Trousseau's syndrome at Clinical

Trial results on Trousseau's syndrome

Clinical Trials on Trousseau's syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Trousseau's syndrome

NICE Guidance on Trousseau's syndrome


FDA on Trousseau's syndrome

CDC on Trousseau's syndrome


Books on Trousseau's syndrome


Trousseau's syndrome in the news

Be alerted to news on Trousseau's syndrome

News trends on Trousseau's syndrome


Blogs on Trousseau's syndrome


Definitions of Trousseau's syndrome

Patient Resources / Community

Patient resources on Trousseau's syndrome

Discussion groups on Trousseau's syndrome

Patient Handouts on Trousseau's syndrome

Directions to Hospitals Treating Trousseau's syndrome

Risk calculators and risk factors for Trousseau's syndrome

Healthcare Provider Resources

Symptoms of Trousseau's syndrome

Causes & Risk Factors for Trousseau's syndrome

Diagnostic studies for Trousseau's syndrome

Treatment of Trousseau's syndrome

Continuing Medical Education (CME)

CME Programs on Trousseau's syndrome


Trousseau's syndrome en Espanol

Trousseau's syndrome en Francais


Trousseau's syndrome in the Marketplace

Patents on Trousseau's syndrome

Experimental / Informatics

List of terms related to Trousseau's syndrome

The Trousseau sign of malignancy or Trousseau's Syndrome is a medical sign involving episodes of vessel inflammation due to blood clot (thrombophlebitis) which are recurrent or appearing in different locations over time (thrombophlebitis migrans or migratory thrombophlebitis). The location of the clot is tender and the clot can be felt as a nodule under the skin.[1] Trousseau's syndrome is a rare variant of venous thromboembolism (VTE) that is characterized by recurrent, migratory thrombosis in superficial veins and in uncommon sites, such as the chest wall and arms. This syndrome is particularly associated with pancreatic and lung cancer [2] Trousseau's sign can be an early sign of gastric or pancreatic cancer,[3] typically appearing months to years before the tumor would be otherwise detected.[4] Heparin therapy is recommended to prevent future clots.[5] The Trousseau sign of malignancy should not be confused with the Trousseau sign of latent tetany caused by hypocalcemia.


Armand Trousseau first described this finding in the 1860s; he later found the same sign in himself, was subsequently diagnosed with pancreatic cancer and died soon thereafter.[6] Dr. Trousseau presciently attributed thromboembolism in malignancy to changes in blood composition rather than local inflammatory or mechanical forces. By correlating clinical observation with surgical and autopsy findings, Dr. Trousseau recognized that a localized cancer could induce a generalized hypercoagulable state in which thrombosis could occur elsewhere in the body, such as in extremities with visceral malignancy. Dr. Trousseau described several cases in which recurrent thrombosis was the presenting feature of visceral cancer, and his confidence in the utility of this connection led him to say, "So great, in my opinion, is the semiotic value of phlegmasia in the cancerous cachexia, that I regard this phlegmasia as a sign of the cancerous diathesis as certain as sanguinolent effusion into the serous cavities."


Some malignancies, especially gliomas (25%), as well as adenocarcinomas of the pancreas and lung, are associated with hypercoagulability (the tendency to form blood clots) for reasons that are incompletely understood, but may be related to factors secreted by the tumors, in particular a circulating pool of cell-derived tissue factor-containing microvesicles.[7] Some adenocarcinomas secrete mucin that can interact with selectin found on platelets, thereby causing small clots to form [8][9]

In patients with malignancy-associated hypercoagulable states, the blood may spontaneously form clots in the portal vessels, the deep veins of the extremities (such as the leg), or the superficial veins anywhere on the body. These clots present as visibly swollen blood vessels (vasculitis), especially the veins, or as intermittent pain in the affected areas.


  1. Trousseau's sign of visceral malignancy in GPnotebook, retrieved November 2012
  2. (Nov 2002) "The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate". Neoplasia: 465-473. doi:10.1038/sj.neo.7900263. Retrieved on 24 April 2015.
  3. Callander, N (1993). "Trousseau's syndrome.". Western Journal of Medicine 158 (4): 364–371. ISSN 0093-0415. PMID 8317122.
  4. Trousseau sign at Dorland's Medical Dictionary
  5. Callander, N (1993). "Trousseau's syndrome.". Western Journal of Medicine 158 (4): 364–371. ISSN 0093-0415. PMID 8317122.
  6. Samuels MA, King ME, Balis U (2002). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2002. A 61-year-old man with headache and multiple infarcts". N. Engl. J. Med. 347 (15): 1187–94. doi:10.1056/NEJMcpc020117. PMID 12374880.
  7. Del Conde I, Bharwani LD, Dietzen DJ, Pendurthi U, Thiagarajan P, López JA.(2007) Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5:70-4
  8. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. (2003) "Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas." J Clin Invest 112: 853-862.
  9. Varki, Ajit (2007). "Trousseau's syndrome: multiple definitions and multiple mechanisms". Blood 110 (6): 1723–1729. doi:10.1182/blood-2006-10-053736. ISSN 0006-4971. PMID 17496204.

Template:Eponymous medical signs for oncology